Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments
rawpixel / Pixabay

Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

According to a story from CRWE World, the genetic medicines company Audentes Therapeutics has recently announced its intent to develop new therapies for myotonic dystrophy and Duchenne muscular dystrophy. These…

Continue Reading Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

The Myotonic Dystrophy Foundation’s Annual Conference

  • Post author:
  • Post category:

The 2018 MDF Annual Conference This event will be open to myotonic dystrophy patients, their families, researchers, health professionals, and caregivers. Attendees will have the opportunity to learn the latest…

Continue Reading The Myotonic Dystrophy Foundation’s Annual Conference

2017 Myotonic Dystrophy Foundation Annual Conference

  • Post author:
  • Post category:

Your Sunshine State Getaway The 2017 Annual MDF Annual Conference Registration fee: $200-$250 — covers all conference events (general and breakout sessions, two evening social receptions, and other informational and…

Continue Reading 2017 Myotonic Dystrophy Foundation Annual Conference